![Catherine Stehman-Breen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Stehman-Breen
Directeur/Membre du Conseil chez
TENAYA THERAPEUTICS, INC.
Fortune : 2 M $ au 31/07/2026
Profil
Catherine Stehman-Breen currently works at Dyne Therapeutics, Inc., as Independent Director from 2019, Tenaya Therapeutics, Inc., as Independent Director from 2020, Atlas Venture Advisors, Inc., as Advisor from 2018, Atlas Venture Life Science Advisors LLC, as Advisor from 2018, UW School of Public Health, as Associate Professor, and F-Prime Inc., as Venture Partner from 2025.
Dr. Stehman-Breen also formerly worked at Chroma Medicine, Inc., as Chief Executive Officer & Director from 2020 to 2024, National Institute of Diabetes & Digestive & Kidney Diseases, as Chairman-United States Renal Data System, Generation Bio Co., as Independent Director from 2017 to 2026, Amgen, Inc., as Vice President-Global Development from 2003 to 2015, Regeneron Pharmaceuticals, Inc., as VP-Clinical Development & Regulatory Affairs from 2015 to 2017, Sarepta Therapeutics, Inc., as Chief Medical Officer in 2017, Obsidian Therapeutics, Inc., as Chief Research & Development Officer from 2019 to 2020, and Disarm Therapeutics, Inc., as Chief Medical Officer from 2018 to 2019.
Dr. Stehman-Breen received her undergraduate degree in 1985 from Colby College, graduate degree in 1996 from the University of Washington, and doctorate degree in 1990 from The University of Chicago.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DYNE THERAPEUTICS INC 0,05 % | 05/06/2026 | 89 467 ( 0,05 % ) | 2 M $ | 31/07/2026 |
| 28/05/2026 | 8 125 ( 0 % ) | 6 013 $ | 31/07/2026 |
Postes actifs de Catherine Stehman-Breen
| Sociétés | Poste | Début |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2019 |
| TENAYA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2020 |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for seed and early stage capital requirements. | Consultant / Advisor | 01/03/2018 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | 01/03/2018 |
UW School of Public Health
 UW School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Private Equity Investor | 01/03/2025 |
Anciens postes connus de Catherine Stehman-Breen
| Sociétés | Poste | Fin |
|---|---|---|
| GENERATION BIO CO. | Directeur/Membre du Conseil | 06/02/2026 |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Directeur Général | 11/12/2024 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Directeur Technique/Scientifique/R&D | 01/12/2020 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Catherine Stehman-Breen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Colby College
 Colby College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institute of Diabetes & Digestive & Kidney Diseases
 National Institute of Diabetes & Digestive & Kidney Diseases General GovernmentGovernment Engages in clinical research on serious diseases | Government |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for seed and early stage capital requirements. | Finance |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat patients with neurological diseases | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
UW School of Public Health
UW School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
